Nový Zbyněk Ph.D.

Nový Zbyněk Ph.D.'s picture
Academic Title: Pharm.D.
Phone: +420 774810713, +420 585632125, +420 585632126
Curriculum Vitae: download
LinkedIn

Researcher experienced in the field of nuclear medicine with the main research interest in preparation and analysis of radiolabeled compounds for microPET/SPECT/CT imaging, biodistribution studies of radiolabeled compounds in vivo and studies of accumulation of radiolabeled compounds in vitro. Published 9 scientific papers, >30 abstracts, >12 SCI citations, H-index 2.


Publications (Impact Factor Journals):

  • [6]
    VRABLIKOVA, A., L. CZERNEKOVA, R. CAHLIKOVA, Z. NOVÝ, M. PETŘÍK, S. IMRAN, Z. NOVÁK, M. KŘUPKA, V. CEROVSKY, J. TURANEK a M. RAŠKA. Lasioglossins LLIII affects the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice. Microbiology and Immunology. 2017, 61(11), 474-481. ISSN 0385-5600. IF: 1.706. PMID: 28892177
  • [5]
    SUMMER, D., L. GROSSRUBATSCHER, M. PETŘÍK, T. MICHALČÍKOVÁ, Z. NOVÝ, C. RANGGER, M. KLINGER, E. VON GUGGENBERG, R. HAUBNER, P. KAEOPOOKUM, H. HAAS a C. DECRISTOFORO. Developing targeted hybrid imaging probes by chelator scaffolding. Bioconjugate Chemistry. 2017, 28(6), 1722-1733. ISSN 1043-1802. IF: 4.500. PMID: 28462989
  • [4]
    PETŘÍK, M., C. ZHAI, Z. NOVÝ, L. URBANEK, H. HAAS a C. DECRISTOFORO. In vitro and in vivo comparison of selected Ga-68 and Zr-89 labelled siderophores. Molecular Imaging and Biology. 2015, 18(3), 344-52. ISSN 1860-2002. IF: 2.569. PMID: 26424719
  • [3]
    PETŘÍK, M., A. VLČKOVÁ, Z. NOVÝ, L. URBANEK, H. HAAS a C. DECRISTOFORO. Selected 68Ga-siderophores versus 68Ga-colloid and 68Ga-citrate: biodistribution and small animal imaging in mice. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2015, 159(1), 60-66. ISSN 1213-8118. IF: 0.924. PMID: 25363728
  • [2]
    NOVÝ, Z., A. LAZNICKOVA, J. MANDIKOVA, P. BARTA, M. LAZNICEK a F. TREJTNAR. The effect of chelator type on in vitro receptor binding and stability in 177Lu-labeled cetuximab and panitumumab. Journal of Labelled Compounds & Radiopharmaceuticals. 2014, 57(7), 448-452. ISSN 1099-1344. IF: 1.273. PMID: 24889367
  • [1]
    MATTOVA, J., P. POUCKOVA, J. KUCKA, M. SKODOVA, M. VETRIK, P. STEPANEK, P. URBANEK, M. PETŘÍK, Z. NOVÝ a M. HRUBY. Chelating polymeric beads as potential therapeutics for Wilson's disease. European Journal of Pharmaceutical Sciences. 2014, 62(-), 1-7. ISSN 0928-0987. IF: 3.350. PMID: 24815561


Master students mentor:

[2] Michaela Holá, Gallium-68 labelled RGD peptides evaluation for imaging of glioblastoma multiforme,
status: Graduated, from: 2014 to 2017
[1] Barbora Planičková, Radiolabeled agents for the diagnosis of prostate cancer,
status: Ongoing, from: 2016


Bachelor students mentor:

[4] Veronika Kašková, Hydroxyapatite nanoparticles as a potential diagnostics of solid tumors,
status: Ongoing, from: 2017
[3] Adam Beňko, Choline derivatives as potential cancer diagnostics and therapeutics,
status: Ongoing, from: 2016
[2] Hana Adámková, Imaging of glioblastoma multiforme in a mouse model using PET/CT system,
status: Graduated, from: 2014 to 2015
[1] Dominika Flašarová, Gallium-68 labelled RGD peptides for PET imaging of glioblastoma multiforme,
status: Graduated, from: 2015 to 2016